Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy (Q34297893)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

anti-retroviral agent

0 references

0 references

author name string

Burman WJ

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jones BE

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7-12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Using therapeutic drug monitoring to dose the antimycobacterial drugs

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Paradoxical expansion of intracranial tuberculomas during chemotherapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

21 January 2018

Identifiers

10.1164/AJRCCM.164.1.2101133

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34297893&oldid=2039664582"